Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hippo Pathway Activation in Aged Mesenchymal Stem Cells Contributes to the Dysregulation of Hepatic Inflammation in Aged Mice. | Adv Sci (Weinh) | 2023 | 37544916 | PubTator, text mining | PubMed |
| TAZ upregulates MIR-224 to inhibit oxidative stress response in multiple myeloma. | Cancer Rep (Hoboken) | 2023 | 37539777 | PubTator, text mining | PubMed |
| Mapping the MOB proteins' proximity network reveals a unique interaction between human MOB3C and the RNase P complex. | J Biol Chem | 2023 | 37536630 | PubTator, text mining | PubMed |
| On-bead purification and nanodisc reconstitution of human chemokine receptor complexes for structural and biophysical studies. | STAR Protoc | 2023 | 37516969 | PubTator, text mining | PubMed |
| Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer. | Pharmaceuticals (Basel) | 2023 | 37513953 | PubTator, text mining | PubMed |
| Time-Course of Transcriptomic Change in the Lungs of F344 Rats Repeatedly Exposed to a Multiwalled Carbon Nanotube in a 2-Year Test. | Nanomaterials (Basel) | 2023 | 37513116 | PubTator, text mining | PubMed |
| mTOR Signaling Pathway and Gut Microbiota in Various Disorders: Mechanisms and Potential Drugs in Pharmacotherapy. | Int J Mol Sci | 2023 | 37511569 | PubTator, text mining | PubMed |
| Therapeutic Potential of EVs: Targeting Cardiovascular Diseases. | Biomedicines | 2023 | 37509546 | PubTator, text mining | PubMed |
| Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: new insights from pathogenic mechanisms to clinically targeted therapy. | J Transl Med | 2023 | 37507803 | PubTator, text mining | PubMed |
| Serine/Threonine Protein Kinase-3 Promotes Oral Squamous Cell Carcinoma by Activating Ras-MAPK Mediated Cell Cycle Progression. | Int J Gen Med | 2023 | 37496599 | PubTator, text mining | PubMed |
| Spontaneous urinary bladder regeneration after subtotal cystectomy increases YAP/WWTR1 signaling and downstream BDNF expression: Implications for smooth muscle injury responses. | PLoS One | 2023 | 37494380 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| RGS16 regulates Hippo-YAP activity to promote esophageal cancer cell proliferation and migration. | Biochem Biophys Res Commun | 2023 | 37473526 | PubTator, text mining | PubMed |
| Malignant mesothelioma tumours: molecular pathogenesis, diagnosis, and therapies accompanying clinical studies. | Front Oncol | 2023 | 37469419 | PubTator, text mining | PubMed |
| LAMP2A, LAMP2B and LAMP2C: similar structures, divergent roles. | Autophagy | 2023 | 37469132 | PubTator, text mining | PubMed |
| Anti-nanodisc antibodies specifically capture nanodiscs and facilitate molecular interaction kinetics studies for membrane protein. | Sci Rep | 2023 | 37468499 | PubTator, text mining | PubMed |
| Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development. | J Transl Med | 2023 | 37461108 | PubTator, text mining | PubMed |
| Dimerization and autophosphorylation of the MST family of kinases are controlled by the same set of residues. | Biochem J | 2023 | 37459121 | PubTator, text mining | PubMed |
| The latest breakthrough on genetic characteristics of inflammatory bowel disease in Chinese and other East Asian ancestries. | Precis Clin Med | 2023 | 37456986 | PubTator, text mining | PubMed |
| Stranger Twins: A Tale of Resemblance and Contrast Between VAP Proteins. | Contact (Thousand Oaks) | 2023 | 37455812 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=21